A review of C-reactive protein: A diagnostic indicator in periodontal medicine

Renuka Devi Ramamoorthy, Vijaykumar Nallasamy, Raghavendra Reddy, Nalini Esther, Yuvaraja Maruthappan, Renuka Devi Ramamoorthy, Vijaykumar Nallasamy, Raghavendra Reddy, Nalini Esther, Yuvaraja Maruthappan

Abstract

Periodontitis is a local inflammatory process mediating the destruction of periodontal tissues, triggered by bacterial insult. Recent evidence suggests the presence of chronic inflammatory periodontal disease may significantly affect systemic health conditions such as coronary heart disease, stroke, or adverse pregnancy outcome. C-reactive protein (CRP) is an acute phase protein which reflects a measure of the acute phase response. CRP is used as one of the markers of choice in monitoring the acute phase response because it increases to a relatively high concentration compared to basal concentration. CRP has been shown to predict cardiovascular (CV) mortality in recent studies, and elevated CRP levels have been observed in middle-aged patients with periodontitis. Combination of chronic infections like periodontitis with elevated CRP is associated with higher chronic heart diseases. The recognition of the relationship between periodontal diseases and atherosclerotic events is relatively recent and mostly based on the inflammatory hypothesis of atherosclerosis. Periodontal disease is one of the risk factors for cardiovascular disease and possibly one of its causes. Hence, even associations of modest magnitude have a large impact. The cost to the society directly attributable to atherosclerotic sequelae is very large. Periodontitis is treatable; moreover, it is preventable. Experimental conformation of this shows that another widely prevalent and preventable contributor to the burden of cardiovascular disease would be added to the options available of the clinicians and public health practitioners for the control of the epidemic of cardiovascular disease.

Keywords: Acute phase reactants; C-reactive protein; cardiovascular disease; periodontal disease.

Conflict of interest statement

Conflict of Interest: None declared.

References

    1. Hussain TM, Kim DH. C-reactive protein and erythrocyte sedimentation rate in orthopaedics. Spring. 2002;15:13–6.
    1. Gabay C, Kusher I. Acute - Phase Proteins and Other Systemic Responses to Inflammation. N Engl J Med. 1999;340:448–54.
    1. Russell R. Atherosclerosis-An Inflammatory Disease. N Engl J Med. 1999;340:115–26.
    1. Pepys MB, Gideon M. Hirschfield - C-reative protein: A critical update. J Clin Invest. 2003;111:1805–12.
    1. Zambson JJ, Reynolds JS, Chen P, Genco RJ, Slots J, Thomas ER. Microbiology of Periodontal Disease. In: Slots J, Taubman JE, editors. USA: St. Louis; 1985. pp. 32–40.
    1. Slade GD, Ghezzi EM, Heiss G, Beck JD, Riche E, Offenbacher S. Relationship Between Periodontal Disease and C-Reactive Protein Among Adults in the Atherosclerosis Risk in Communities Study. Arch Intern Med. 2003;163:1172–9.
    1. Beck J, Garcia R, Heiss G, Vokonas PS, Offenbacher S. Periodontal Disease and Cardio Vascular Disease. J Periodontol. 1996;67(10 Suppl):1123–37.
    1. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-Reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med. 2003;342:836–43.
    1. Kervinen H. Studies on inflammatory markers in the prediction of coronary heart disease risk. Thesis, University of helsenki feb 2005. Available at: Wihuri Research Institute. Helsenki .
    1. Sabet M, Lee SW, Nauman RK, Sims T, Um H-S. The Surface (S-) Layer is a virulence factor of Bacteroides forsythus. Microbiology. 2003;149:3617–27.
    1. Williamson D. Research finds periodontal disease, body mass index jointly associated with heart disease protein marker .UNC News Services 2003-No. 298
    1. Birkedal-Hansen H. Role of Matrix Metalloproteinases in Human Periodontal Diseases. J Periodontal. 1993:474–84.
    1. Slade GD, Offenbacher S, Beck JD, Heiss G, Pankow JS. Acute-phase Inflammatory Response to Periodontal Disease in the US Population. J Dent Res. 2000;79:49–57.
    1. Dave S, Batista EL, Jr, van Dyke TE. Cardiovascular Disease and Periodontal diseases: Commonality and causation. Compend Contin Educ Dent. 2004;25:7 Suppl 1.
    1. Mariotti A. A Primer on Inflammation. Compendium. 2004;25(suppl-1):7–15.
    1. Shapira L, Soskolne WA, Sela MN, Offenbacher S, Barak V. The secretion of PGE2, IL-1 beta, IL-6 and TNF alpha by adherent mononuclear cells from early onset periodontitis patients. J Periodontol. 1994;65:139–46.
    1. Loos BG, Craandijk J, Hoek FJ, Paulein ME, Wertheim-van Dillen PM, van der Velden U. Elevation of Systemic Markers Related to Cardiovascular Diseases in the Peripheral Blood of Periodontitis Patients. J Periodontal. 2000;71:1528–34.
    1. Potempa J, Banbula A, Travis J. Role of Bacterial Proteinases in matrix destruction and modulation of host responses. Periodontol. 2000;24:153–92.
    1. Amar S, Han X. The impact of periodontal infection on systemic diseases. Med Sci Monit. 2003;9:RA291–9.
    1. Ishikawa I, Nakashima K, Koseki T. Toshiyuki Nagawa Induction of the immune response to periodontopathic bacteria and its role in the Pathogenesis of Periodontitis. Periodontol. 2000;1997(14):79–111.
    1. Joseph VC, Robert ES, John CG, Ai MB, Harvey AS, John GT. Antibody reactive with prophyr Monas gingivalis serotypes K1-6 in Adlut and generalized early - onset periodonttis. J Periodondol. 1999;70:730–5.
    1. Biasucci LM, Liuzzo G. Fillippo -Acute coronary syndrome. J Am Coll Cardiol. 2008;52(18):1500–01.
    1. Nystrom T. C- reactive protein: A marker or player ? Clin Sci. 2007;113:79–81.
    1. Asikainen S, Alaluusua S, Saxen L. The Recovery of Actinobacllus Actinomycetemcomitans. J Periodontol. 1991:203–6.
    1. Mattila K, Vesanen M, Valtonen V, Nieminen M, Paiosuo T, Rasi V, et al. Effect of treating periodontitis on C-reactive protein levels: A pilot study. BMC Infect Dis. 2002;2:30.
    1. Chalmers JD, Singanayagam A, Hill AT. C-Reactive Protein is an independent predictor of severity in community - acquired pneumonia. Am J Med. 2008;121:219–25.

Source: PubMed

Sponzoři a spolupracovníci

Zdravotní podmínky

Drogové intervence

3
Předplatit